Airway Clearance Devices Market - By Device Type (Oscillatory Positive Expiratory Pressure, High Frequency Chest Wall Oscillation, Intrapulmonary Percussive Ventilation), Application (Bronchiectasis, Cystic Fibrosis), End-use, & Forecast, 2024 – 2032

Airway Clearance Devices Market Size

Airway Clearance Devices Market size was valued at around USD 646.2 million in 2023 and is expected to reach over USD 1 billion by 2032 at a CAGR of 5.1% during the forecast period. Growing patient volume suffering from respiratory related disorders such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, among others are expected to fuel the market growth as they require effective management to improve patients' quality of life.
 

Airway clearance devices are essential in reducing mucus buildup, which is crucial for patients with such chronic conditions. For instance, according to the World Health Organization (WHO), COPD is the third leading cause of deaths worldwide. With an increasing number of patients requiring effective management of chronic respiratory diseases, the demand for advanced and efficient airway clearance devices continues to grow. Additionally, governments and health organizations are conducting campaigns to educate public about respiratory health, therapeutic respiratory devices and the importance of managing chronic respiratory conditions. Increased awareness leads to early diagnosis and proactive management, driving demand for airway clearance devices.
 

Airway clearance devices are medical devices designed to help clear mucus and other secretions from the airways. The primary goal of airway clearance devices is to improve lung function, reduce the risk of infections, and enhance the overall quality of life for individuals with respiratory conditions.  
 

Airway Clearance Devices Market Trends

Technological advancements in the market are significantly enhancing the efficacy, convenience, and user experience of these products. Innovations such as high-frequency chest wall oscillation (HFCWO), oscillating positive expiratory pressure, automated mechanical insufflation-exsufflation, portable and wearable devices, and smart technology integration are driving market growth.
 

• HFCWO devices use external chest wall oscillation to help loosen and mobilize mucus from the airways, making it easier for patients to clear their airways. These devices are particularly beneficial for patients with conditions such as cystic fibrosis and bronchiectasis.
   
• For instance, the latest models now feature advanced programming options and improved user interfaces, which significantly enhance patient comfort and therapy adherence. Hillrom’s SmartVest Connect, equipped with wireless technology, enables remote monitoring and data sharing with healthcare providers, facilitating better management of respiratory conditions.
   
• Additionally, the Aerobika OPEP device is designed for ease of use, portability, and efficient mucus clearance. Recent updates have improved device ergonomics and durability, making it a favored option for patients with chronic respiratory issues.
   
• Similarly, the AffloVest is a fully mobile, battery-operated HFCWO vest that delivers high-frequency chest wall oscillation therapy. The latest versions offer multiple treatment modes, adjustable intensity levels, and are designed to be lightweight and comfortable, thereby enhancing patient compliance. These innovations provide patients with more effective and accessible solutions for managing chronic respiratory conditions, ultimately leading to improved treatment outcomes and a better quality of life.
   

Airway Clearance Devices Market Analysis

Based on device type, the market is categorized into oscillatory positive expiratory pressure (OPEP), high frequency chest wall oscillation (HFCWO), intrapulmonary percussive ventilation (IPV), and other devices. The oscillatory positive expiratory pressure (OPEP) segment held significant market share and is projected to record fastest growth with a 5.5% CAGR during the forecast period.
 

• OPEP devices are generally handheld, portable, and easy to use, making them accessible for a wide range of patients, including children and elderly patients.  
   
• Moreover, OPEP devices effectively combine positive expiratory pressure with oscillations to mobilize and clear mucus from the airways. This dual action enhances mucus clearance and improves lung function, increasing product demand in the market.
   

Based on application, the airway clearance devices market is segmented into chronic obstructive pulmonary disease (COPD), bronchiectasis, cystic fibrosis, neuromuscular, and other applications. The chronic obstructive pulmonary disease (COPD) segment held majority market share with a revenue of around USD 422.3 million in 2032.
 

• COPD is a chronic condition that requires regular monitoring and treatment through airway management devices. This chronic nature ensures a sustained demand for airway clearance devices as part of the long-term care plan for patients.  
   
• Moreover, COPD significantly impacts patients quality of life due to symptoms such as breathlessness and chronic mucus accumulation. Airway clearance devices play a crucial role in alleviating these symptoms, improving lung function, and enhancing daily living activities, hence increasing their demand in the market.
   

Based on end-use, the airway clearance devices market is categorized into home care settings, hospitals, and other end-users. The home care settings segment held substantial market share with a revenue of around USD 403.8 million in 2023.
 

• Managing respiratory conditions at home significantly reduces the need for hospitalizations and emergency care, leading to lower healthcare costs for both patients and healthcare systems.
   
• Moreover, many respiratory conditions require ongoing, long-term management. Home care settings provide a practical and sustainable solution for patients needing daily or regular use of airway clearance devices, thus, contribute to segmental growth.
   

North America airway clearance devices market accounted for USD 255.6 million in revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• The high level of healthcare expenditure in North America supports the adoption of advanced medical devices, including airway clearance devices. Patients and healthcare providers are willing to invest more in effective treatment options.
   
• Additionally, increased awareness among patients about the importance of managing respiratory conditions and the availability of airway clearance devices drives market growth.
   

The U.S. airway clearance devices market is anticipated to reach USD 288.3 million by 2032, driven by numerous factors.
 

• The U.S. healthcare system is known for its advanced infrastructure and access to cutting-edge medical technology, facilitating the development and adoption of innovative airway clearance devices.
   
• Furthermore, high level of healthcare spending in the country support the adoption of advanced medical devices, including airway clearance devices.
   

The airway clearance devices market in UK is expected to experience significant and promising growth from 2024 to 2032.
 

• Initiatives by government bodies and health organizations to raise awareness about respiratory health and the importance of managing chronic conditions drive the adoption of airway clearance devices.
   
• Additionally, there is an increasing trend toward home-based healthcare solutions, driven by patient preference for convenience and comfort. Portable and easy-to-use airway clearance devices are well-suited for home care settings.
   

Japan airway clearance devices market is anticipated to witness lucrative growth between 2024 – 2032.
 

• The presence of significant percentage of geriatric population group in the country is anticipated to spur the product demand throughout the analysis period.
   
• Furthermore, comprehensive insurance coverage in Japan often includes airway clearance devices, making them more affordable and accessible to patients.
   

Airway Clearance Devices Market Share

The airway clearance devices industry is consolidated in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel devices with improved efficiency and cost-effectiveness are key market strategies for medical device manufacturers, driving competition and innovation in the airway clearance devices industry. This emphasis on innovation aims to address evolving clinical needs and enhance patient outcomes, positioning companies to gain market share and meet the growing demand for advanced airway clearance devices.
 

Airway Clearance Devices Market Companies

Some of the eminent market participants operating in the airway clearance devices industry include:

• ABM Respiratory Care
• Dymedso Inc.
• Electromed Inc.
• Hill-Rom Holdings, Inc./Baxter International
• ICU Medical
• Koninklijke Philips N.V.
• Mercury Medical
• Monaghan Medical Corporation
• Pari Medical Holding GmbH
• Pneumo Care Health Private Limited.
• Tactile Medical
• Thayer Medical
• VORTRAN Medical Technology 1 Inc.
• Vyaire Medical, Inc.
   

Airway Clearance Devices Industry News:

• In November 2023, Electromed, Inc. announced its launch of the SmartVest Clearway Airway Clearance System to the hospital market for inpatient use. With this launch the company improved its product offerings and its reputation in the market.
   
• In January 2023, ABM Respiratory Care BiWaze Clear System received U.S. FDA 510 (K) clearance. This product approval improved the company’s customer base and enhanced its competitiveness.
   

Airway clearance devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million and volume (Units) from 2021 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Device Type  

• Oscillatory positive expiratory pressure (OPEP)
• High frequency chest wall oscillation (HFCWO)
• Intrapulmonary percussive ventilation (IPV)
• Other device types

Market, By Application  

• Chronic obstructive pulmonary disease (COPD)
• Bronchiectasis
• Cystic fibrosis
• Neuromuscular
• Other applications

Market, By End-use

• Home care settings
• Hospitals
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa